QSAR of antimycobacterial activity of benzoxazoles by optimal SMILES-based descriptors
- 139 Downloads
The CORAL software based on the optimal descriptors calculated with simplified molecular input-line entry system was used to build up quantitatively structure-activity relationship for the minimal inhibition concentrations against (i) Mycobacterium tuberculosis H37RV ATCC 27294 and (ii) M. tuberculosis drug resistant clinical isolate. The predictive potential of these models has been checked up with three random splits into the training, calibration, and validation sets. Although all models are quantitative, it has been found that splitting have apparent influence on the statistical quality of these models. Thus, the thesis “QSAR is a random event” is confirmed in this work.
KeywordsQSAR Antimycobacterial activity Benzoxazoles CORAL software SMILES
A.A.T. and A.P.T thank the project LIFE-COMBASE contract (LIFE15 ENV/ES/000416) for financial support. I.Y. and T.E.-B. thank the Research Fund of Ankara University (Grant No: 12B3336002) for the financial support.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- ACD/ChemSketch (2016) Advanced Chemistry Development, Toronto, Canada. http://www.acdlabs.com/products/draw_nom/draw/chemsketch/. Accessed 20 June 2016
- Connolly MY (2010) Quantitative drug design, a critical introduction, 2nd edn. CRC Press, Boca RatonGoogle Scholar
- CORAL (2016) http://www.insilico.eu/CORAL. Accessed 20 June 2016
- Kumar A, Chauhan S (2017a) QSAR differential model for prediction of SIRT1 modulation using monte carlo method. Drug Res 67:156–162Google Scholar
- Kumar A, Chauhan S (2017b) Use of the monte carlo method for OECD principles-guided QSAR modeling of SIRT1 inhibitors. Arch Pharm 350, article no. e1600268Google Scholar
- Sokolović D, Aleksić D, Milenković V, Karaleić S, Mitić D, Kocić J, Mekić B, Veselinović JB, Veselinović AM (2016a) QSAR modeling of bis-quinolinium and bis-isoquinolinium compounds as acetylcholine esterase inhibitors based on the Monte Carlo method—the implication for Myasthenia gravis treatment. Med Chem Res 25:2989–2998CrossRefGoogle Scholar
- Sokolović D, Stanković V, Toskić D, Lilić L, Ranković G, Ranković J, Nedin-Ranković G, Veselinović AM (2016b) Monte Carlo-based QSAR modeling of dimeric pyridinium compounds and drug design of new potent acetylcholine esterase inhibitors for potential therapy of myasthenia gravis. Struct Chem 27:1511–1519CrossRefGoogle Scholar
- Toropov AA, Toropova AP, Benfenati E, Nicolotti O, Carotti A, Nesmerak K, Veselinović AM, Veselinović JB, Duchowicz PR, Bacelo D, Castro EA, Rasulev BF, Leszczynska D, Leszczynski J (2015) QSPR/QSAR analyses by means of the CORAL software: results, challenges, perspectives. In: Roy K (ed) Quantitative structure-activity relationships in drug design, predictive toxicology and risk assessment. IGI Global, Hershey, pp 560–585CrossRefGoogle Scholar
- Toropova AP, Toropov AA, Diaza RG, Benfenati E, Gini G (2011b) Analysis of the co-evolutions of correlations as a tool for QSAR-modeling of carcinogenicity. An unexpected good prediction based on a model that seems untrustworthy. Cent Eur J Chem 9:165–174Google Scholar